View:     View:
tid Target Cancers General Effect on Target
Name
Source
Type

BCAP (B-cell adaptor for phosphoinositide 3-kinase) expression has been studied in various types of cancer, particularly in B-cell malignancies.
BCAP is primarily expressed in B-cells, and its expression levels can be altered in B-cell malignancies such as chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), and other lymphomas.
BCAP is involved in the PI3K signaling pathway, which is crucial for cell growth, survival, and metabolism.
Some studies suggest that BCAP may be involved in the signaling pathways that affect tumor growth and metastasis. High BCAP expression could correlate with poor prognosis in certain subtypes of breast cancer.




(Will delete Record if Target field = "Delete")
 Home